BRIEF published on 05/17/2024 at 15:05, 1 year 10 months ago Protenus reconnu pour l'excellence en milieu de travail en 2024 Protenus Analyse Des Soins De Santé La Satisfaction Des Employés Excellence Du Lieu De Travail Certification Great Place To Work
BRIEF published on 05/17/2024 at 15:05, 1 year 10 months ago Protenus Recognized for Workplace Excellence in 2024 Employee Satisfaction Protenus Healthcare Analytics Workplace Excellence Great Place To Work Certification
PRESS RELEASE published on 05/17/2024 at 15:00, 1 year 10 months ago Protenus Earns Esteemed Workplace Honors for 2024 Protenus recognized as one of the 2024 Modern Healthcare Best Places to Work in Healthcare and a Great Place to Work® for the fifth year, highlighting commitment to employee well-being and workplace culture Healthcare Compliance Work-life Balance Protenus Great Place To Work® Employee-centric Culture
BRIEF published on 04/04/2024 at 16:05, 2 years ago Protenus remporte un accord de solutions logicielles de détournement de médicaments avec Premier, Inc. Protenus Conformité Des Soins De Santé Premier Inc. Prévention Du Détournement De Drogues Technologie De Surveillance
BRIEF published on 04/04/2024 at 16:05, 2 years ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Healthcare Compliance Protenus Premier Inc. Drug Diversion Prevention Surveillance Technology
PRESS RELEASE published on 04/04/2024 at 16:00, 2 years ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Protenus awarded national group purchasing agreement with Premier, Inc. for Drug Diversion Software Solutions, offering Premier members special pricing and terms for Protenus solution Healthcare Protenus Premier Inc. Drug Diversion Supplier Contract
BRIEF published on 04/02/2024 at 16:05, 2 years ago Protenus Secures Two Innovative Patents for Enhancing Healthcare Compliance Healthcare Compliance Protenus Patient Privacy Monitoring Technology Innovation U.S. Patents
BRIEF published on 04/02/2024 at 16:05, 2 years ago Protenus obtient deux brevets innovants pour améliorer la conformité des soins de santé Innovation Technologique Protenus Conformité Des Soins De Santé Surveillance De La Confidentialité Des Patients Brevets Américains
PRESS RELEASE published on 04/02/2024 at 16:00, 2 years ago Protenus Granted Two New Patents for Healthcare Compliance Protenus expands patient privacy monitoring technology with new patents to help hospitals identify record breaches. CEO emphasizes AI-driven solutions for protecting patient data Protenus Healthcare Compliance Analytics Patient Privacy Monitoring New Patents Data Breach
BRIEF published on 03/26/2024 at 16:05, 2 years ago Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology Artificial Intelligence Healthcare Compliance Protenus Drug Diversion Surveillance Patent Grant
Published on 04/07/2026 at 15:00, 2 hours 31 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 2 hours 46 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 2 hours 51 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 3 hours 1 minute ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 3 hours 1 minute ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 16:32, 59 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 1 hour 1 minute ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 2 hours 31 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 2 hours 36 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 14:42, 2 hours 49 minutes ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition
Published on 04/07/2026 at 16:43, 47 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010318386
Published on 04/07/2026 at 16:43, 47 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010318386
Published on 04/07/2026 at 16:18, 1 hour 13 minutes ago NRJ Group - Information relative aux droits de vote au 31.03.2026 (French & English)
Published on 04/07/2026 at 14:44, 2 hours 47 minutes ago Statement of transactions in own shares from March 30, 2026 to April 2, 2026
